Jane Street
SGMO

Jane Street’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Jane Street’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.5K Buy
317,800
+232,200
+271% +$92.4K ﹤0.01% 10756
2025
Q4 		$36K Buy
85,600
+37,400
+78% +$19.8K ﹤0.01% 10595
2025
Q3 		$32.5K Sell
48,200
-40,300
-46% -$21.7K ﹤0.01% 10441
2025
Q2 		$47.9K Buy
88,500
+34,700
+64% +$20.6K ﹤0.01% 9185
2025
Q1 		$35.3K Sell
53,800
-23,800
-31% -$25.2K ﹤0.01% 9067
2024
Q4 		$79.2K Buy
77,600
+62,400
+411% +$114K ﹤0.01% 8848
2024
Q3 		$13.2K Buy
+15,200
New +$11.1K ﹤0.01% 9330
2023
Q1 		– Sell
-21,800
Closed -$68.5K – 9827
2022
Q4 		$68.5K Sell
21,800
-12,600
-37% -$48.9K ﹤0.01% 8260
2022
Q3 		$169K Buy
34,400
+12,400
+56% +$63.7K ﹤0.01% 8316
2022
Q2 		$91K Buy
22,000
+3,000
+16% +$13K ﹤0.01% 8690
2022
Q1 		$110K Sell
19,000
-74,100
-80% -$441K ﹤0.01% 9409
2021
Q4 		$698K Buy
93,100
+38,400
+70% +$334K ﹤0.01% 6636
2021
Q3 		$493K Sell
54,700
-41,900
-43% -$414K ﹤0.01% 7300
2021
Q2 		$1.16M Sell
96,600
-57,600
-37% -$652K ﹤0.01% 5524
2021
Q1 		$1.93M Sell
154,200
-134,600
-47% -$1.81M ﹤0.01% 4088
2020
Q4 		$4.51M Buy
288,800
+211,300
+273% +$2.48M ﹤0.01% 2266
2020
Q3 		$732K Sell
77,500
-78,800
-50% -$852K ﹤0.01% 4596
2020
Q2 		$1.4M Buy
156,300
+137,500
+731% +$1.28M ﹤0.01% 3580
2020
Q1 		$120K Buy
+18,800
New +$139K ﹤0.01% 4876
2019
Q1 		– Sell
-15,100
Closed -$173K – 5564
2018
Q4 		$173K Sell
15,100
-4,800
-24% -$59.6K ﹤0.01% 4523
2018
Q3 		$337K Buy
+19,900
New +$302K ﹤0.01% 4071
2018
Q2 		– Sell
-25,100
Closed -$477K – 5546
2018
Q1 		$477K Buy
25,100
+8,500
+51% +$182K ﹤0.01% 3510
2017
Q4 		$272K Buy
+16,600
New +$247K ﹤0.01% 3876
2016
Q1 		– Sell
-17,800
Closed -$163K – 4588
2015
Q4 		$163K Buy
+17,800
New +$137K ﹤0.01% 3684

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's SGMO Position: Q1 2026 in Review

Jane Street sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 2,918,127 shares — an estimated $1.16M sold.

Jane Street first reported a position in SGMO in Q2 2013 and held it in 34 quarters. The position peaked at $2.89M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Jane Street reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 2,918,127 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $1.16M.
  • Jane Street first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 34 quarters.
  • Jane Street's SANGAMO THERAPEUTICS INC position peaked at $2.89M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.